HKU5 bat merbecoviruses engage bat and mink ACE2 as entry receptors
Mia Madel Alfajaro(Yale University), Craig B. Wilen(Yale University), Danyi Wang, Akiko Iwasaki(Yale University), Aleksandra Synowiec(Jagiellonian University), Ralph S. Baric(University of North Carolina at Chapel Hill), John D. Huck(Yale University), Walther Mothes(Yale University), Gabriel A Russell(Yale University), Arthur S. Kim(Scripps Research Institute), Daniel C. Douek(Institut de Recherche Vaccinale), Alicen B. Spaulding(National Institutes of Health), Pradeep D. Uchil(Yale University), John G. Doench(Broad Institute), Boyd L. Yount(University of North Carolina at Chapel Hill), Nicholas Catanzaro(University of North Carolina at Chapel Hill), Aaron M. Ring(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Leonid Serebryannyy(National Institutes of Health), Rohit K. Jangra(Louisiana State University Health Sciences Center Shreveport), Emma L. Keeler(Yale University), Mario A. Peña-Hernández(Yale University), Yaroslav Tsybovsky(Frederick National Laboratory for Cancer Research), Samantha K. Zepeda(University of Washington), Jaewon Song(Brown University), Bridget L. Menasché(Yale University), Jin Wei(Yale University), Alexandra Schäfer(University of North Carolina at Chapel Hill), I‐Ting Teng(National Institutes of Health), Sanghyun Lee(Washington University in St. Louis), Ramandeep Kaur(Government Medical College, Amritsar), Zhe Zhao(Yale University), Ning Li(Frederick National Laboratory for Cancer Research), David R. Martinez(Yale University), Tongqing Zhou(National Institutes of Health), Ridwan Arinola(Louisiana State University Health Sciences Center Shreveport), Michael W. Grunst(Yale University)
Cited by 5
Related Papers
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
|Nature Communications|2020|1.8k
Microbiota regulates immune defense against respiratory tract influenza A virus infection
|Proceedings of the National Academy of Sciences|2011|1.5k